WallStSmart

Braskem SA Class A (BAK)vsCelanese Corporation (CE)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 627% more annual revenue ($70.60B vs $9.71B). BAK leads profitability with a -7.8% profit margin vs -12.0%. BAK appears more attractively valued with a PEG of 1.46. BAK earns a higher WallStSmart Score of 52/100 (C-).

BAK

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

CE

Hold

45

out of 100

Grade: D+

Growth: 3.3Profit: 3.5Value: 5.0Quality: 3.5
Piotroski: 3/9Altman Z: 1.28
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

CEUndervalued (+29.5%)

Margin of Safety

+29.5%

Fair Value

$85.95

Current Price

$47.09

$38.86 discount

UndervaluedFair: $85.95Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

CE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$377.34M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

CE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.422/10

Expensive relative to growth rate

Return on EquityProfitability
-26.9%2/10

ROE of -26.9% — below average capital efficiency

EPS GrowthGrowth
-37.1%2/10

Earnings declined 37.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : CE

The strongest argument for CE centers on Price/Book.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : CE

The primary concerns for CE are Piotroski F-Score, PEG Ratio, Return on Equity. Debt-to-equity of 2.96 is elevated, increasing financial risk.

Key Dynamics to Monitor

BAK profiles as a growth stock while CE is a turnaround play — different risk/reward profiles.

CE carries more volatility with a beta of 0.76 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

CE generates stronger free cash flow (147M), providing more financial flexibility.

Bottom Line

BAK scores higher overall (52/100 vs 45/100) and 21.6% revenue growth. CE offers better value entry with a 29.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Celanese Corporation

BASIC MATERIALS · CHEMICALS · USA

Celanese Corporation is a Fortune 500 global technology and specialty materials company headquartered in Irving, Texas, United States.

Want to dig deeper into these stocks?